Publicacións (48) Publicacións nas que participase algún/ha investigador/a

2024

  1. A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 8, pp. 1794-1800

  2. Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 5

  3. Acute Hepatitis in Children Due to Rat Hepatitis E Virus

    Journal of Pediatrics, Vol. 273

  4. Addressing Sexually Transmitted Infections Due to Neisseria gonorrhoeae in the Present and Future

    Microorganisms, Vol. 12, Núm. 5

  5. Amniotic Membrane Transplantation in the Management of Corneal Ulceration Following Infectious Keratitis

    Ocular Immunology and Inflammation, Vol. 32, Núm. 7, pp. 1261-1267

  6. Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain)

    Gastroenterologia y Hepatologia

  7. Assessment of performance and comparison of three commercial HDV RNA detection assays: implications for diagnosis and treatment monitoring

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  8. Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis

    JMIR public health and surveillance, Vol. 10, pp. e54503

  9. Association of microbiological factors with mortality in Escherichia coli bacteraemia presenting with sepsis/septic shock: a prospective cohort study

    Clinical Microbiology and Infection, Vol. 30, Núm. 8, pp. 1035-1041

  10. Auritidibacter ignavus in ear discharge of paediatric patients: Two cases reports and literature review

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 4, pp. 202-204

  11. Clinical and Microbiological Risk Factors for 30-Day Mortality of Bloodstream Infections Caused by OXA-48-Producing Klebsiella pneumoniae

    Pathogens, Vol. 13, Núm. 1

  12. Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 10, pp. 2011-2022

  13. Comparative analysis of eleven SARS-CoV-2 immunoassays and neutralisation data: time to enhance standardisation and correlation of protection

    Infectious Diseases

  14. Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 279-296

  15. Detection and quantification of HBV and HCV in plasma samples by means of different molecular assays: Comparative study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 1, pp. 13-16

  16. Dientamoeba fragilis: An emerging pathogen

    Enfermedades Infecciosas y Microbiologia Clinica

  17. Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study

    Annals of Clinical Microbiology and Antimicrobials, Vol. 23, Núm. 1

  18. Dispersal history of SARS-CoV-2 in Galicia, Spain

    Journal of Medical Virology, Vol. 96, Núm. 7

  19. Draft genome sequence of Klebsiella pneumoniae KLEB-33: a convergent biofilm hyperforming multiresistant strain belonging to the emerging ST16 lineage harboring multiple hypervirulence genes

    Microbiology Resource Announcements, Vol. 13, Núm. 4

  20. Early Antibiotic De-escalation in Patients With Severe Infections Due to Bloodstream Infection by Enterobacterales: A Post Hoc Analysis of a Prospective Multicentre Cohort

    International Journal of Antimicrobial Agents, Vol. 64, Núm. 5